ASX - By Stock
|
RXM |
Re:
Ann: Results of Meeting
|
|
l
|
12 |
3.9K |
7 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
12
|
3.9K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
l
|
1.0K |
389K |
17 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Breakout
|
|
l
|
144 |
47K |
9 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
144
|
47K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Breakout
|
|
l
|
144 |
47K |
4 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
144
|
47K
|
4
|
|
ASX - By Stock
|
RXM |
Re:
Ann: Rex at Euroz Conference, WA
|
|
l
|
12 |
5.7K |
4 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
12
|
5.7K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
l
|
267 |
64K |
4 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
267
|
64K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
l
|
267 |
64K |
3 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
267
|
64K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD
|
|
l
|
211 |
72K |
24 |
01/01/22 |
01/01/22 |
ASX - By Stock
|
211
|
72K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
l
|
850 |
249K |
5 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
850
|
249K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
l
|
850 |
249K |
4 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
249K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Global CardioVascular Clinical Trialists Forum Presentation
|
|
l
|
21 |
7.8K |
14 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
21
|
7.8K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Q1 Financial Results and Operational Highlights
|
|
l
|
124 |
38K |
7 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
124
|
38K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Q1 Financial Results and Operational Highlights
|
|
l
|
124 |
38K |
14 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
124
|
38K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: First Quarter Results Presentation
|
|
l
|
7 |
3.4K |
12 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
7
|
3.4K
|
12
|
|
ASX - By Stock
|
PSC |
Re:
Ann: $18 Million Placement to Advance Arcadia
|
|
l
|
180 |
48K |
8 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
180
|
48K
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
Nature publication
|
|
l
|
32 |
12K |
7 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
32
|
12K
|
7
|
|
ASX - By Stock
|
PSC |
Re:
General PSC Chat/Discussion
|
|
l
|
1.6K |
435K |
9 |
15/10/21 |
15/10/21 |
ASX - By Stock
|
1.6K
|
435K
|
9
|
|
ASX - By Stock
|
PSC |
Re:
General PSC Chat/Discussion
|
|
l
|
1.6K |
435K |
6 |
01/10/21 |
01/10/21 |
ASX - By Stock
|
1.6K
|
435K
|
6
|
|
ASX - By Stock
|
PSC |
Re:
General PSC Chat/Discussion
|
|
l
|
1.6K |
435K |
10 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
1.6K
|
435K
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
l
|
10K |
3.0M |
10 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Financial Results Presentation
|
|
l
|
77 |
22K |
5 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
77
|
22K
|
5
|
|
ASX - By Stock
|
PSC |
Re:
Ann: Arcadia Partnership Process and OFS Update
|
|
l
|
27 |
9.6K |
23 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
27
|
9.6K
|
23
|
|
ASX - By Stock
|
BSX |
Re:
Media
|
|
l
|
2.6K |
653K |
6 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
2.6K
|
653K
|
6
|
|
ASX - By Stock
|
BSX |
Re:
Media
|
|
l
|
2.6K |
653K |
19 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
2.6K
|
653K
|
19
|
|
ASX - By Stock
|
CLB |
Re:
Ann: Change of Director's Interest Notice
|
|
l
|
14 |
2.9K |
1 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
14
|
2.9K
|
1
|
|
ASX - By Stock
|
RXM |
Re:
Ann: Rex announces successful completion of A$50m Placement
|
|
l
|
99 |
43K |
11 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
99
|
43K
|
11
|
|
ASX - By Stock
|
GWR |
Re:
Ann: Haulage Record Set & Stage 2 Pit Ore Crushing Commenced
|
|
l
|
21 |
7.6K |
9 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
21
|
7.6K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
l
|
9.4K |
2.7M |
8 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
9.4K
|
2.7M
|
8
|
|
ASX - By Stock
|
BSX |
Re:
Ann: Blackstone Completes Ta Khoa Refinery Pre-feasibilty Study
|
|
l
|
115 |
35K |
9 |
26/07/21 |
26/07/21 |
ASX - By Stock
|
115
|
35K
|
9
|
|
ASX - By Stock
|
PSC |
Re:
General PSC Chat/Discussion
|
|
l
|
1.6K |
435K |
8 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
1.6K
|
435K
|
8
|
|
ASX - By Stock
|
CLB |
Re:
Ann: Proposed issue of securities - CLB
|
|
l
|
12 |
2.8K |
1 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
12
|
2.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
l
|
17K |
6.6M |
0 |
17/07/21 |
17/07/21 |
ASX - By Stock
|
17K
|
6.6M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Australian Newspaper MSB trial failure
|
|
l
|
255 |
70K |
12 |
17/07/21 |
17/07/21 |
ASX - By Stock
|
255
|
70K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Respiratory Outcomes Presented
|
|
l
|
163 |
60K |
9 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
163
|
60K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Results Presentation
|
|
l
|
33 |
13K |
9 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
33
|
13K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Results Presentation
|
|
l
|
33 |
13K |
4 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
33
|
13K
|
4
|
|
ASX - By Stock
|
QPM |
Re:
Ann: Noosa Conference Presentation
|
|
l
|
26 |
8.8K |
6 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
26
|
8.8K
|
6
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Investor Day Presentation
|
|
l
|
5 |
2.1K |
2 |
05/07/21 |
05/07/21 |
ASX - By Stock
|
5
|
2.1K
|
2
|
|
ASX - By Stock
|
FEX |
Re:
Media Releases
|
|
l
|
843 |
285K |
22 |
03/07/21 |
03/07/21 |
ASX - By Stock
|
843
|
285K
|
22
|
|
ASX - By Stock
|
PSC |
Re:
General PSC Chat/Discussion
|
|
l
|
1.6K |
435K |
12 |
03/07/21 |
03/07/21 |
ASX - By Stock
|
1.6K
|
435K
|
12
|
|
ASX - By Stock
|
QPM |
Re:
Medium Term Target: A$1+ billion market cap
|
|
l
|
2.2K |
793K |
1 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
2.2K
|
793K
|
1
|
|
ASX - By Stock
|
QPM |
Re:
Medium Term Target: A$1+ billion market cap
|
|
l
|
2.2K |
793K |
3 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
2.2K
|
793K
|
3
|
|
ASX - By Stock
|
QPM |
Re:
Ann: Investment and Offtake Agreement with LGES and POSCO
|
|
l
|
375 |
123K |
20 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
375
|
123K
|
20
|
|
ASX - By Stock
|
RXM |
Re:
VIDEO: REX INTERVIEW WITH THE MARKET HERALD
|
|
l
|
4 |
2.6K |
9 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
4
|
2.6K
|
9
|
|
ASX - By Stock
|
A4N |
Re:
Ann: Accelerating Production with Precursor Production Facility
|
|
l
|
68 |
17K |
0 |
01/06/21 |
01/06/21 |
ASX - By Stock
|
68
|
17K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
l
|
1.6K |
460K |
2 |
16/05/21 |
16/05/21 |
ASX - By Stock
|
1.6K
|
460K
|
2
|
|
ASX - By Stock
|
CLB |
Re:
Ann: Quarterly Activities Report & Appendix 4C
|
|
l
|
91 |
27K |
3 |
10/05/21 |
10/05/21 |
ASX - By Stock
|
91
|
27K
|
3
|
|
ASX - By Stock
|
RXM |
Re:
RXM Breakout - 38c next stop
|
|
l
|
191 |
76K |
4 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
191
|
76K
|
4
|
|
ASX - By Stock
|
RXM |
Re:
Ann: Rex successfully completes A$9.5M Placement
|
|
l
|
19 |
7.4K |
10 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
19
|
7.4K
|
10
|
|
ASX - By Stock
|
RXM |
10m tonne copper deficit by 2030
|
|
l
|
51 |
20K |
3 |
03/04/21 |
03/04/21 |
ASX - By Stock
|
51
|
20K
|
3
|
|